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Abstract
In recent years, substantive attention has been drawn to the relationship between oral microbiome homeostatic 
equilibrium disruption and systemic health, demonstrating the negative impacts of this reciprocal biological interplay. 
Increasingly, there is a concern over the potential noxious effect of oral microbiome dysbiosis on obstetric poor 
outcomes, focusing on preterm birth. This epidemiological observation remains unexplained, although biologically 
plausible mechanism has been proposed. Intrauterine infection has long been associated with adverse pregnancy, 
when the elicitation of an immune response is determinant. There is evidence that Fusobacterium nucleatum (FN), a 
Gram-negative anaerobe ubiquitous in the oral cavity, infects the mouse placenta originating in the decidua basalis. 
Based on the current data in literature, we performed a review to provide resources for the explanation of the 
potential impact of microbiome dysbiosis on poor obstetric outcomes, focusing on the role of FN.
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Introduction
Periodontal disease and oral microbiome
It has been increasingly recognized that 
alteration of oral microbiome is responsible for 
modulating systemic disorders at least might be 
partially caused by periodontal pathogens translocation 
[1], [2], [3]. The establishment of microbiome dysbiosis 
can exert detrimental effects on the immune system. 
Several systemic disorders have been intimately 
blended with periodontal inflammation, but its relation 
to poor obstetric outcomes is less convincing [4], 
[5], [6], [7]. It is ascertained that the periodontitis is 
related to the elevation of systemic levels of a specific 
inflammatory marker (C-reactive-protein) and pro-
inflammatory cytokines [8]. This association is based 
on the range of the evidence furnished by the empirical 
studies which have supported this assumption [9], 
[10], [11]. For example, in the seat of diabetes, it has 
been observed a deleterious impact of periodontitis on 
glycemic control for by enhancing the general immune 
responsiveness [12]. It has been established that the 
oral microbiota is critically modified during diabetes, 
and the disruption of oral microbiome eubiosis [13], [14], 
[15] determines a feedback loop in which host and cell 
components and metabolites of microbial community 
regulate each other, leading to a perpetuation of the 
dysbiotic condition [16], [17], [18]. It seems probable 
that analogous results would be produced on the 
amniotic fluid of pregnant women [19]. Any interference 
which its internal action may show an immune reactivity 
[20], [21], [22]. The oral microbiome during periodontitis 
is characterized by lower phylogenetic diversity and 
pathobiont overgrowth [23]. The exciting cause of this 
affection is a dysregulation of the oral microbiome. This 
enables reason to conceptualize the role of periodontal 
infection process in abstraction from the restriction of 
limited confined infection as the condition of its ability 
of sustaining a low-grade systemic inflammatory status 
[24]. The construction of this theory and expansion of 
the role of peripheral inflammation has posed essential 
questions for analysis of the dysregulation of oral 
microbiome [25], [26]. Therefore, the potential damaging 
effect of periodontal pathogens in pregnant women is 
its tendency to cause low-grade systemic inflammation, 
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which may lead to premature rupture of membranes 
[18]. Whether the impact from periodontal infection 
influences or explicates a direct effect is uncertain but 
suggests a potentially damaging interaction between 
periodontitis and preterm delivery (PTD) [23]. From 
the empirical findings, a clear interest focused on 
the placental inflammation has emerged [1], [4], [25], 
[26], [27], [28], [29]. Central relationship between the 
periodontal disease and preterm birth (PTB) is due 
to an inflammatory response system responding to 
signal from bacterial invasion [30], [31]. Interestingly, 
a similarity between placental and oral microbiome 
was found to be essential to describe as coherent a 
hypothesis of relationship between oral dysbiosis and 
pregnancy poor outcomes [32], [33], [34], [35], [36], [37]. 
This hypothesis is referred to an activate inflammatory 
signaling pathways stimulated by periodontal damage, 
or direct dissemination of periodontal pathogens 
through hematogenous spread from the oral cavity 
[18], [21], [27], [35], but they do not fully explain such 
behaviors, suggesting that other mechanisms and 
factors might play a key role in determining the link 
[22], [23], [24], [25]. Fusobacterium nucleatum (FN) is 
an opportunistic commensal Gram-negative anaerobe 
microorganism ubiquitous to the oral cavity, one of 
the most abundant pathogens implicated in severe 
periodontal disease [18], [38], [39], [40], [41], [42], [43], 
[44], [45], [46]. A collective body of evidence suggests 
an interconnection in times of homeostasis and disease 
and reveals a highly prevalence of this oral pathogen 
in intrauterine infection. FN has been isolated from the 
amniotic cavity, placenta, chorioamniotic membranes of 
women delivering prematurely, and fetus. Further, it has 
been identified in the blood vessels in murine placentas 
[47]. However, Fusobacterium spp. is common isolate 
in vaginal microbiota, representing a potential source of 
amniotic fluid colonization.
The relationship between the oral 
microbiome and PTB
The pathogenesis of PTB is composite and 
only incompletely identified [1]. In addition to a genetic 
susceptibility, the main elements responsible for the 
premature delivery include environmental factors and 
infectious agents [2], [3], [36], [37], [38]. Increased 
expression of the Th1 cytokines IL-2 and IL-12, and 
IFN gamma in placentas from the PTD and premature 
rupture of membranes women has been observed 
[39], [40], [41], [42], [43], [44], [45], and there is 
increasing evidence that the pathogenic colonization 
of the intrauterine space leads to placental high-grade 
inflammatory response [40]. In recent years, substantive 
attention has been drawn to the relationship between 
the oral microbiome homeostatic equilibrium disruption 
and systemic health, demonstrating the negative 
impacts of this reciprocal biological interplay [41], [43]. 
In this novel specific context, several researchers have 
an interest in analyzing the meaning of the potential 
impact of oral microbiome variations on poor pregnancy 
outcomes [45], [46], [47]. However, the actual models 
concerning the biological mechanism underlying the 
potential relationship between oral microbial community 
and PTB concern the oral microbiote role, whereby the 
oral microbiote might be responsible for the colonization 
of placental membranes and basal plate decidua [11], 
[12], [13], [14], [15]. A multitude of studies has identified 
potential periodontal pathogens that might have a 
causal role in determining the risk of PTB, evaluating 
the combined influences of genes with intrinsic and 
extrinsic environmental factor [46], [47], [48], [49]. The 
balance of the oral microbiome is conditioned on the 
biological resources, environmental modifications, and 
the development of sui generis species variety. Patients 
with persistent periodontitis have a chronic immune 
reaction which reflects increments in the systemic 
concentration of tumor necrosis factor-α, IL-1β, IL-6, and 
C-reactive protein among other inflammatory mediators 
[16], [33], [49]. Thus, anomalous immunoregulatory 
circuit can contribute to the etiology of inflammation-
related disease [23], [33], [49], [50], [51]. The 
neuroendocrine/immune system interaction during 
pregnancy is part of broadly physiological events with 
the panoply of associated alterations, involving also 
the oral microbiote composition [16], [17], [32], [52]. 
The exposure to these hormonal changes is postulated 
to trigger the oral microbial community shift, resulting 
in the manifestation of more disruptive periodontitis 
[18], [19], [20], [21], [53], [54], [55], [56]. This transition 
may provide an explanation of understanding the 
relationship between periodontal pathogens and PTB 
[56], [57], [58], [59].
The linkage between FN and PTB
The oral cavity encompasses a number of 
bacteria that share many virulence characteristics 
and that may be capable of causing a low-grade 
systemic inflammation [16], [17], [18], [19], [31], [45], 
[48], [59]. However, instead of contributing on systemic 
alterations, some periodontal pathogens seem to 
disseminate overcoming the placental barrier leading 
to localized placental inflammation, triggering preterm 
membrane rupture [3], [4], [5], [6], [7], [8], [9], [10], 
[11], [12], [13], [14], [15], [16], [17], [18], [19], [45], [51]. 
The oral microbiome in pregnancy has been widely 
investigated to study the contributions of potential 
translocated periodontal pathogens to PTB risk [18], 
[29]. Specifically, it has been investigated the role 
of the Gram-negative periodontal pathogen FN, an 
opportunistic pathogen agent having a specific role in the 
pathogenesis of different periodontal conditions, and it 
is increasingly recognized as an important agent of PTB 
[42], [50]. FN is credited with the distinction of being the 
most crucial pathogen implicated in the pathogenesis 
of periodontitis [26], [27], [28], [29], [30], [31], [32], 
[33], [34], [35], [36], [37], [38], [39], [40], [41], [42], 
[43], counting its systemic effects on immune system 
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[59], [60]. The localized infection and inflammation of 
the mouse placenta mediated by oral FN colonization 
have been described previously by several researchers 
who suggested that the hematogenous transmission of 
this bacterium had a detrimental effect on pregnancy, 
producing intrauterine inflammatory response [51]. 
FN has been isolated from amniotic fluid at a different 
gestational age [52], [53]. Concurrent chorioamnionitis 
at term with intact membranes has been associated 
with the presence of FN in the amniotic fluid. However, 
these reports, although no descriptions of underlying 
mechanism were given, confirm the presence of the 
FN suggesting a need of clarification of its role [52], 
[53]. The human oral microbiome represents a dynamic 
ecosystem comprising >700 different species [52], 
[61]. The colonization characteristics of pathogenic 
bacteria in the placenta are important to understand 
their potential role in PTB risk [54], [62]. FN is the type 
species of the genus Fusobacterium, belonging to the 
family Bacteroidaceae [12], [43]. FN is categorized 
into five subspecies (FN subsp. nucleatum, FN subsp. 
polymorphum, FN subsp. fusiforme, FN subsp. vincentii, 
and FN subsp. animalis) on the basis of the several 
phenotypic characteristics and DNA homology. It is a 
Gram-negative, non-spore-forming obligate anaerobe, 
having a G1C content of 27–28 mol% and a genome 
size of about 2.4 3 106 bp. It is one of the most common 
periodontal species associated with periodontitis and it 
has already been adverted for its power to spread over 
a periodontal site and establish an efficient systemic 
inflammatory response [27], [28]. This linkage may be 
determined by the ability of the pathogen to colonize 
the placenta, through its ability to adhere and invade 
the host epithelial and endothelial cells through FadA 
adhesin, a virulence factor, which may be involved in 
pathogenesis of intrauterine infection [26], [27], [28], 
[29], [30]. It has been suggested that the subsequent 
affection of the placenta may be probably induced 
through colonization, exciting the premature rupture 
of fetal membranes, because of the inflammation may 
assume an unhealthy character, in consequence of 
the severity of the infection [33], [34], [35]. The most 
conventional model describing the relevant biological 
mechanism underlying the relationship between oral 
pathogens and PTB is highly empirical. The hypothesis, 
therefore, often describes based on hematogenous 
spread to explain the involvement of oral microbiota 
as cause of intrauterine infection [32], [36]. Compelling 
evidence supporting systemic exposure to the Gram 
negative derived the lypopolysaccharides, responsible 
for much of the toxicity of pathogen bacteria, 
characterized by the ability to trigger a cascade of 
responses ultimately. The role of FN virulence factors 
in placenta invasion was verified by deletion and 
complementation experiments [12]. The FN invasion 
triggers the Toll-like receptor 4-mediated activation 
of localized inflammatory response, responsible of 
preterm membrane rupture [53]. In the closed emerging 
link, the potential interdependence existing between 
FN and PTB has been amply explored. Besides the 
relevance of FN, extensively examined in several 
available articles, it has been discussed a relevant 
issue that is strictly related to FN genomics, and genetic 
significance of heterogeneity, particularly based on 
metagenomic approach, to evaluate FN’s contribution 
to PTB, and the genetic magnitude of FN heterogeneity, 
which is intrinsically linked to virulence aspects.
Pathogenic Mechanism of FN: The role of 
Fusobacterium adhesin A (FadA)
The association with PTB has been widely 
investigated, emphasizing the ability of Fn to disseminate 
into the organism adhering and invading endothelial, 
through the binding to the vascular endothelial (VE) 
cadherin (CDH5) [16], [33]. The ability of the pathogen 
to colonize the placenta may be determined by its facility 
to adhere and invade host epithelial and endothelial 
cells through a FadA adhesin, a virulence factor, which 
may be involved in pathogenesis of intrauterine infection 
[18], [19]. The adhesin FadA is a virulence factor 
isolated from FN, occurring in two forms: The intact 
non-secreted form pre-FadA, composed of 129 amino 
acid (aa) residues and mature FadA monomer (mFadA) 
secreted form mFadA of 111 aa. The combination of 
these monomers leads to the constitution of the active 
complex FadAc, characterized by heterogeneous 
filaments. Cristal structure of FadA adhesin reveals an 
intercellular oligomerization mechanism for bacterial 
aggregation [28], [29], [30]. Studies aimed to elucidating 
the process of FN translocation into host cells, include 
genetic analysis defining components that are required 
for FadA activity [18], [21], [30]. This is exemplified by 
the identification of the VE-cadherin as a potential FadA 
receptor. FadA has been identified to play critical role for 
strong bacterial surface proteins binding and invasion 
of host cells [16], [19]. This binding is conferred by the 
minor fimbrial component. It was found that the binding 
of FadA (for Fusobacterium adhesin A) to epithelial 
cadherin (E-cadherin) is required for bacterial adhesion 
and invasion of host cells [35], [38]. It has been 
demonstrated that FadA adhesion gene (fadA) may 
be a microbial determinant contributing to placental 
invasion, causing a localized inflammatory response, 
responsible for fetal demise prematurely [29], [30], [31], 
[32]. The role of Fusobacterium adhesion A in PTB was 
first reported in pregnant mice infected with FN [37], 
[38], [39], [40], [41], [54], [59], [60], [61]. It was the 
first genetic complementation study which confirmed 
that the promotion of cellular invasion and placental 
colonization mediated by the exposure of FadA, 
through construction of FN 12230 USF81, a fadA-
complementing clone. In this study, the mechanisms by 
which EAEC 042 triggers this inflammatory event were 
assessed. The immunofluorescent staining analysis of 
expression of FadA on the FN 12230 USF81 strain, fad-
A-complementing clone, confirmed that FadA is equally 
exposed on the bacterial cell surface, promoting 
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adherence and invasion of host cells [59], [60], [61]. This 
study provided the first evidence that the expression of 
FadA was correlated to placental colonization in vivo 
[60]. Studies aimed at elucidating the process of FN 
translocation into host cells, include genetic analysis 
defining components that are required for FadA activity 
[32]. This is exemplified by the identification of the 
VE-cadherin as a potential FadA receptor [33].
Conclusions
As stressed above, the capacity of translocation 
of periodontal pathogens is the prerequisite for establishing 
the relationship, because instead of contributing on 
systemic alterations, some periodontal pathogens seem 
to disseminate overcoming the placental barrier leading 
to localized placental inflammation, triggering preterm 
membrane rupture [25], [26]. Specifically, it has been 
investigated the role of the Gram-negative periodontal 
pathogen FN, an opportunistic pathogen agent having 
a specific role in pathogenesis of different periodontal 
conditions [1], [4], [8], [9], [10], [11], [12], [13], [14], [15], 
[16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], and 
it is increasingly recognized as an important agent of PTB. 
A multitude of studies has identified potential periodontal 
pathogens that might have a causal role in determining 
the risk of PTB, evaluating the combined influences of 
genes with intrinsic and extrinsic environmental factors 
[45], [46], [47], [48]. These investigations have been 
pivotal in providing resources for the explanation of the 
potential impact of microbiome dysbiosis on poor obstetric 
outcomes [15], [16], [17], [18], [19], [20], [21], [22], [23], 
[24], [25], [26]. It has been increasingly recognized 
that alteration of oral microbiome is responsible for 
modulating systemic disorders [25], [26]. Meta-analytic 
evidence supports the concept of a biunivocal relationship 
between periodontal infection and systemic diseases as 
measured by inflammatory markers level across a wide 
range of biomarkers [35], [36], [37], [38], [39], [40], [41], 
[42], [43], [44], [45], [46]. Longitudinal studies reveal the 
aforementioned correlation with a broad spectrum of 
systemic diseases, such as cardiovascular diseases, 
neurodegenerative disorders can worsen because of 
establishing low-grade inflammatory process driven by 
dysbiosis of oral microbiome. Although ample studies 
have [15], [21], [22], [23], [24], [25], [26], [27] demonstrated 
the effect of periodontal infection on systemic immune 
response, there is still a paucity of information 
regarding the interaction between periodontitis and 
poor obstetric outcomes [51], [52], [53], [54], [55], [56]. 
However, substantially less is known about the potential 
association of periodontitis with PTB [18]. That said, the 
most recent research into the potential correlation of 
noxious effects of oral microbiome dysbiosis in the host 
microbiome crosstalk and poor obstetric outcomes [39] 
has concluded that this interconnection has substantial 
support, but the general ecosystem destabilization during 
pregnancy and potentially other factors has be yet to be 
elucidate [43]. The study of PTB-periodontitis relation 
has long been interested in the way in which two actors 
can enhance mutual gains [22], [27], [38]. Despite the 
extensive research intended to achieve this objective, 
there is still a great deal of ambiguity as to the periodontal 
pathogen sustain this outcome. Whereas the investigation 
of periodontal pathogen [21] is largely restricted to the 
research arena, the use of short-read sequencing 
approach is not well established in clinical periodontology 
[45], [46], [47], [48], [49], [50], [51], [52], [53], [54], [55], 
[56]. Through analyzing the dynamic character of the 
oral microbial communities and their interactions with the 
organism, we sought to reveal through which way the 
association between periodontal disease and general 
health is understand and interpreted, focus on the 
relationship between oral microbiome and pregnancy 
[11]. There has been considerable debate as to whether 
the oral microbiome should be seen [13] as a risk factor 
for PTB and whether this induced [26] development of 
new care strategies in response to the changed scientific 
discoveries [60]. However, it seems clear that the new 
conceptualization has critical function through the idea 
of overlapping microbial community specificity and pro-
inflammatory response [13], [15]. Further evidence for 
the assumption that the oral microbiome alteration may 
trigger a specific systemic reaction can be adduced by 
considering the period before the emergence of modern 
concept of this relationship [1], [2], [3], [4], [5], [6], [7], [8], 
[9], [10], [11], [12], [13], [14], [21]. The notion concerning 
the role of transient microbiome is a relatively recent 
phenomenon, because the majority of researchers 
pointed out on the role of pro-inflammatory cytokines only 
[52]. An integrated model that explains the connection 
remains absent. The transdisciplinary approach that 
considers the dynamism and complexity of oral microbial 
communities [49] might be the key to describing 
pathways to explain the impact of periodontitis on PTB. 
Thus, understanding of this influence is pivotal in the 
determination [32] of whether the criterion of this heuristic 
concept is applicable, which can be of assistance in 
determining a subversion of traditional knowledge on 
systemic pathologic conditions [50].
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